Literature DB >> 23772613

The oral mucosa immune environment and oral transmission of HIV/SIV.

Lianna F Wood1, Ann Chahroudi, Hui-Ling Chen, Heather B Jaspan, Donald L Sodora.   

Abstract

The global spread of human immunodeficiency virus (HIV) is dependent on the ability of this virus to efficiently cross from one host to the next by traversing a mucosal membrane. Unraveling how mucosal exposure of HIV results in systemic infection is critical for the development of effective therapeutic strategies. This review focuses on understanding the immune events associated with the oral route of transmission (via breastfeeding or sexual oral intercourse), which occurs across the oral and/or gastrointestinal mucosa. Studies in both humans and simian immunodeficiency virus (SIV) monkey models have identified viral changes and immune events associated with oral HIV/SIV exposure. This review covers our current knowledge of HIV oral transmission in both infants and adults, the use of SIV models in understanding early immune events, oral immune factors that modulate HIV/SIV susceptibility (including mucosal inflammation), and interventions that may impact oral HIV transmission rates. Understanding the factors that influence oral HIV transmission will provide the foundation for developing immune therapeutic and vaccine strategies that can protect both infants and adults from oral HIV transmission.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23772613      PMCID: PMC3821196          DOI: 10.1111/imr.12078

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  281 in total

1.  Epithelial uptake and transport of cell-free human immunodeficiency virus type 1 and gp120-coated microparticles.

Authors:  A Kage; E Shoolian; K Rokos; M Ozel; R Nuck; W Reutter; E Köttgen; G Pauli
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  Per-contact risk of human immunodeficiency virus transmission between male sexual partners.

Authors:  E Vittinghoff; J Douglas; F Judson; D McKirnan; K MacQueen; S P Buchbinder
Journal:  Am J Epidemiol       Date:  1999-08-01       Impact factor: 4.897

3.  Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV.

Authors:  P Becquart; H Hocini; M Lévy; A Sépou; M D Kazatchkine; L Bélec
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

4.  Transmission of macrophage-tropic HIV-1 by breast-milk macrophages via DC-SIGN.

Authors:  Misao Satomi; Masumi Shimizu; Eiji Shinya; Eiji Watari; Atsuko Owaki; Chizuno Hidaka; Masao Ichikawa; Toshiyuki Takeshita; Hidemi Takahashi
Journal:  J Infect Dis       Date:  2004-12-14       Impact factor: 5.226

5.  Evaluating the risk of HIV transmission through unprotected orogenital sex.

Authors:  Jorge del Romero; Beatriz Marincovich; Jesús Castilla; Soledad García; Julián Campo; Victoria Hernando; Carmen Rodríguez
Journal:  AIDS       Date:  2002-06-14       Impact factor: 4.177

6.  Inhibition of human immunodeficiency virus type 1 by lactic acid bacteria from human breastmilk.

Authors:  Virginia Martín; Antonio Maldonado; Leónides Fernández; Juan M Rodríguez; Ruth I Connor
Journal:  Breastfeed Med       Date:  2010-08       Impact factor: 1.817

7.  Coagulation biomarkers predict disease progression in SIV-infected nonhuman primates.

Authors:  Ivona Pandrea; Elaine Cornell; Cara Wilson; Ruy M Ribeiro; Dongzhu Ma; Jan Kristoff; Cuiling Xu; George S Haret-Richter; Anita Trichel; Cristian Apetrei; Alan Landay; Russell Tracy
Journal:  Blood       Date:  2012-05-31       Impact factor: 22.113

8.  Associations between breast milk viral load, mastitis, exclusive breast-feeding, and postnatal transmission of HIV.

Authors:  Kevin M Lunney; Peter Iliff; Kuda Mutasa; Robert Ntozini; Laurence S Magder; Lawrence H Moulton; Jean H Humphrey
Journal:  Clin Infect Dis       Date:  2010-03-01       Impact factor: 9.079

9.  Simian immunodeficiency virus of African green monkeys is apathogenic in the newborn natural host.

Authors:  B Beer; J Denner; C R Brown; S Norley; J zur Megede; C Coulibaly; R Plesker; S Holzammer; M Baier; V M Hirsch; R Kurth
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-07-01

10.  CD4+ T cells spontaneously producing human immunodeficiency virus type I in breast milk from women with or without antiretroviral drugs.

Authors:  Diane Valea; Edouard Tuaillon; Yassine Al Tabaa; François Rouet; Pierre-Alain Rubbo; Nicolas Meda; Vincent Foulongne; Karine Bollore; Nicolas Nagot; Philippe Van de Perre; Jean-Pierre Vendrell
Journal:  Retrovirology       Date:  2011-05-13       Impact factor: 4.602

View more
  9 in total

1.  The well-tempered SIV infection: Pathogenesis of SIV infection in natural hosts in the wild, with emphasis on virus transmission and early events post-infection that may contribute to protection from disease progression.

Authors:  Kevin Raehtz; Ivona Pandrea; Cristian Apetrei
Journal:  Infect Genet Evol       Date:  2016-07-06       Impact factor: 3.342

2.  Natural killer cell and T-cell subset distributions and activation influence susceptibility to perinatal HIV-1 infection.

Authors:  Melanie A Gasper; Pratima Kunwar; Grace Itaya; Nicholas Lejarcegui; Rose Bosire; Elizabeth Maleche-Obimbo; Dalton Wamalwa; Jennifer Slyker; Julie Overbaugh; Helen Horton; Donald L Sodora; Grace John-Stewart; Barbara Lohman-Payne
Journal:  AIDS       Date:  2014-05-15       Impact factor: 4.177

3.  Marginal Effects of Systemic CCR5 Blockade with Maraviroc on Oral Simian Immunodeficiency Virus Transmission to Infant Macaques.

Authors:  Egidio Brocca-Cofano; Cuiling Xu; Katherine S Wetzel; Mackenzie L Cottrell; Benjamin B Policicchio; Kevin D Raehtz; Dongzhu Ma; Tammy Dunsmore; George S Haret-Richter; Karam Musaitif; Brandon F Keele; Angela D Kashuba; Ronald G Collman; Ivona Pandrea; Cristian Apetrei
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

4.  Human beta-defensins 2 and -3 cointernalize with human immunodeficiency virus via heparan sulfate proteoglycans and reduce infectivity of intracellular virions in tonsil epithelial cells.

Authors:  Rossana Herrera; Michael Morris; Kristina Rosbe; Zhimin Feng; Aaron Weinberg; Sharof Tugizov
Journal:  Virology       Date:  2015-11-02       Impact factor: 3.616

5.  Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study.

Authors:  Mariia Patyka; Daniel Malamud; Drew Weissman; William R Abrams; Zoya Kurago
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

Review 6.  HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation.

Authors:  Samantha E Heron; Shokrollah Elahi
Journal:  Front Immunol       Date:  2017-03-07       Impact factor: 7.561

7.  Maternal but Not Infant Anti-HIV-1 Neutralizing Antibody Response Associates with Enhanced Transmission and Infant Morbidity.

Authors:  Melissa Ghulam-Smith; Alex Olson; Laura F White; Charles S Chasela; Sascha R Ellington; Athena P Kourtis; Denise J Jamieson; Gerald Tegha; Charles M van der Horst; Manish Sagar
Journal:  mBio       Date:  2017-10-24       Impact factor: 7.867

8.  Pathogenesis of oral FIV infection.

Authors:  Craig Miller; Karen Boegler; Scott Carver; Martha MacMillan; Helle Bielefeldt-Ohmann; Sue VandeWoude
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

9.  Localization of infection in neonatal rhesus macaques after oral viral challenge.

Authors:  Roslyn A Taylor; Michael D McRaven; Ann M Carias; Meegan R Anderson; Edgar Matias; Mariluz Araínga; Edward J Allen; Kenneth A Rogers; Sandeep Gupta; Viraj Kulkarni; Samir Lakhashe; Ramon Lorenzo-Redondo; Yanique Thomas; Amanda Strickland; Francois J Villinger; Ruth M Ruprecht; Thomas J Hope
Journal:  PLoS Pathog       Date:  2021-11-18       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.